Portfolio Notes: Track, journal, and analyze every trade

Harvard Bioscience, Inc.

Contributing Author

Recent Articles by Harvard Bioscience, Inc.

Mar-12	Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results HBIO GlobeNewswire
Mar-06	Harvard Bioscience Announces Reverse Stock Split HBIO -11.64% HBIO GlobeNewswire
Mar-03	Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum HBIO GlobeNewswire
Feb-26	Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET HBIO GlobeNewswire
Feb-10	Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas HBIO +13.37% GlobeNewswire
Jan-29	Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth HBIO -6.65% HBIO -6.29% GlobeNewswire
Dec-17	Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package HBIO +12.43% GlobeNewswire
Nov-06	Harvard Bioscience Announces Third Quarter 2025 Financial Results HBIO -7.29% GlobeNewswire
Oct-30	Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET HBIO +41.10% GlobeNewswire
Sep-16	Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States HBIO +10.33% GlobeNewswire
Sep-09	Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors HBIO GlobeNewswire
Aug-11	Harvard Bioscience Announces Second Quarter 2025 Financial Results HBIO -9.25% GlobeNewswire
Aug-04	Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET HBIO +10.89% HBIO GlobeNewswire
Jul-17	Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board HBIO +12.07% GlobeNewswire
Jun-02	Harvard Bioscience Appoints John Duke to Board of Directors HBIO -13.19% GlobeNewswire
May-12	Harvard Bioscience Announces First Quarter 2025 Financial Results HBIO +11.78% GlobeNewswire
May-05	Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET HBIO -9.06% HBIO -5.12% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)